TLV Equity Snapshot

CANF Weekly Equity Report

Can-Fite BioPharma Ltd.

Interactive chart JSON snapshot
Latest Close 424.3 ILA 12 Jun 2026
1W Return -7.5% latest completed week
4W Return -18.2% short-term follow-through
12W Return -19.7% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
Company Brief

What the company does

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cancer; and Phase IIa for the treatment of pancreatic cancer; as well as in Phase IIb trial for the treatment of metabolic associated steatohepatitis; and CF602, which is in pre-clinical trial for the treatment …

Snapshot

What the weekly tape is saying

CANF closed the latest completed week at 424.3 ILA. The 4-week return is -18.2% and the 12-week return is -19.7%. Trend Signal is inactive, Market Dynamics is 0.28. Setup signature: Risk-first tape with a 13/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -62.7%
Volume 0.7x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 0 Persistence of active Trend Signal over the last year and current streak.
Momentum 0 Blend of 4-week and 12-week follow-through.
Dynamics 51 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 28 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
1,139 ILA
Vs Trend Line
-62.7%
Fair Value
6,048 ILA
Vs Fair Value
-93.0%
52W High
4,200 ILA
52W Low
422.1 ILA
Drawdown
-89.9%
Range Position
0.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -7.5%
4W -18.2%
12W -19.7%
26W -85.9%
52W -89.1%

Trend read

Active Streak
0 weeks
52W Active Weeks
0
52W Active Breadth
0.0%
Sector Scope
IL Healthcare
Sector Rank
45 of 51
Sector Percentile
12.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.28
4W MD Change
-48.6%
Relative Strength
-84.11
4W RS Change
-0.6%
Expectation
Negative
Probability
24.94%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
64.4K
13W Average
98.3K
52W Average
41.1K
Vs 13W
0.7x
Vs 52W
1.6x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
5.6%
52W Volatility
11.5%
Upside Weeks
10
Downside Weeks
17
Downside Breadth
32.7%
Avg Gain / Loss
3.6% / -10.6%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
TLV
Country
IL
Sector
Healthcare
Industry
Biotechnology
Currency
ILA
Market Cap
19.9M

Opportunity signals

  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 424.3 ILA -7.5% 1,139 ILA 6,048 ILA 0.28 -84.11 64.4K Off
5 Jun 2026 458.8 ILA -2.0% 1,224 ILA 6,114 ILA 0.38 -83.22 65.7K Off
29 May 2026 468.0 ILA -3.4% 1,309 ILA 6,175 ILA 0.49 -84.28 28.2K Off
22 May 2026 484.5 ILA -6.6% 1,393 ILA 6,230 ILA 0.60 -84.11 77.0K Off
15 May 2026 519.0 ILA 4.4% 1,477 ILA 6,278 ILA 0.54 -83.58 97.6K Off
8 May 2026 497.1 ILA 8.2% 1,560 ILA 6,325 ILA 0.47 -85.26 213.1K Off
1 May 2026 459.3 ILA -5.2% 1,643 ILA 6,370 ILA 0.26 -86.62 492.9K Off
24 Apr 2026 484.6 ILA 1.1% 1,728 ILA 6,411 ILA 0.01 -86.25 12.7K Off
17 Apr 2026 479.3 ILA -1.0% 1,812 ILA 6,450 ILA -0.16 -87.06 30.8K Off
10 Apr 2026 484.3 ILA -4.8% 1,896 ILA 6,490 ILA -0.33 -87.55 29.9K Off
3 Apr 2026 508.6 ILA -2.8% 1,980 ILA 6,527 ILA -0.36 -86.75 45.3K Off
27 Mar 2026 523.2 ILA -1.0% 2,063 ILA 6,577 ILA -0.45 -86.69 39.6K Off
20 Mar 2026 528.7 ILA -15.6% 2,145 ILA 6,628 ILA -0.56 -87.75 81.0K Off
13 Mar 2026 626.3 ILA -16.8% 2,228 ILA 6,678 ILA -0.68 -85.61 164.3K Off